Matrigel cytometry: A novel method for quantifying angiogenesis in vivo

Journal of Immunological Methods

Volumn 342, Issue 1-2, 2009, Pages 78-81

  Adini, A ^a   Fainaru, O ^a   Udagawa, T ^a   Connor, K M ^a   Folkman, J ^a   D'Amato, R J ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Angiogenesis; CD31; CD45; Endothelial cells; MADCAM1; Matrigel

Indexed keywords

CD31 ANTIGEN; CD45 ANTIGEN; MATRIGEL; MUCOSAL ADDRESSIN CELL ADHESION MOLECULE 1; PROTEINASE;

ANALYTIC METHOD; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN; DRUG COMBINATIONS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTOR 2; FLOW CYTOMETRY; HUMANS; LAMININ; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEOGLYCANS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MUS;

EID: 59949083331     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2008.11.016     Document Type: Article

References (17)

1. Auerbach R., Akhtar N., Lewis R.L., and Shinners B.L. Angiogenesis assays: problems and pitfalls. Cancer Metastasis Rev. 19 (2000) 167
2. Auerbach R., Auerbach W., and Polakowski I. Assays for angiogenesis: a review. Pharmacol. Ther. 51 (1991) 1
3. Auerbach R., Lewis R., Shinners B., Kubai L., and Akhtar N. Angiogenesis assays: a critical overview. Clin. Chem. 49 (2003) 32
4. Benelli R., and Albini A. In vitro models of angiogenesis: the use of Matrigel. Int. J. Biol. Markers 14 (1999) 243
5. D'Amato R.J., Loughnan M.S., Flynn E., and Folkman J. Thalidomide is an inhibitor of angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 4082
6. Dellian M., Witwer B.P., Salehi H.A., Yuan F., and Jain R.K. Quantitation and physiological characterization of angiogenic vessels in mice: effect of basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor, and host microenvironment. Am. J. Pathol. 149 (1996) 59
7. Fidler I.J. Critical determinants of cancer metastasis: rationale for therapy. Cancer Chemother. Pharmacol. 43 Suppl (1999) S3
8. Folkman J. Tumor angiogenesis. Adv. Cancer Res. 19 (1974) 331
9. Folkman J. Angiogenesis research: from laboratory to clinic. Forum (Genova) 9 (1999) 59
10. Folkman J. Angiogenesis. Annu. Rev. Med. 57 (2006) 1
11. Folkman J. Angiogenesis: an organizing principle for drug discovery?. Nat. Rev. Drug Discov. 6 (2007) 273
12. Guedez L., Rivera A.M., Salloum R., Miller M.L., Diegmueller J.J., Bungay P.M., and Stetler-Stevenson W.G. Quantitative assessment of angiogenic responses by the directed in vivo angiogenesis assay. Am. J. Pathol. 162 (2003) 1431
13. Jain R.K., Schlenger K., Hockel M., and Yuan F. Quantitative angiogenesis assays: progress and problems. Nat. Med. 3 (1997) 1203
14. McCarty M.F., Baker C.H., Bucana C.D., and Fidler I.J. Quantitative and qualitative in vivo angiogenesis assay. Int. J. Oncol. 21 (2002) 5
15. Nico B., Vacca A., De Giorgis M., Roncali L., and Ribatti D. Vascular endothelial growth factor and vascular endothelial growth factor receptor-2 expression in the chick embryo area vasculosa. Histochem. J. 33 (2001) 283
16. Norrby K. In vivo models of angiogenesis. J. Cell. Mol. Med. 10 (2006) 588
17. Rogers M.S., Birsner A.E., and D'Amato R.J. The mouse cornea micropocket angiogenesis assay. Nat. Protoc. 2 (2007) 2545